«ALKERMES»に関連するポーランド語の本
以下の図書目録から
alkermesの使いかたを見つけましょう。
alkermesに関する本とポーランド語文献で使われた文脈を提供するための簡単な抜粋文。
1
The Economics of Contracts: Theories and Applications - Strona 378
Indeed, a case study of the contractual relationship between Alkermes and Genentech in Arora and Merges (2001) shows how patents are used to structure technology licensing agreements. Alkermes has a proprietary, microencapsulation, ...
Eric Brousseau, Jean-Michel Glachant,
2002
2
Libation, A Bitter Alchemy - Strona 92
For serving, you can spoon a little of the alkermes over each slice and garnish with fresh whipped cream. another way to present the dessert is to pour some liqueur in a shallow dish, cut each portion in half horizontally, dip the cut face of the ...
3
Plunkett's Companion to the Almanac of American Employers ...
FEATURES: Drug Delivery Systems Pulmonary Drug Delivery Systems Sustained Release Injection Delivery Systems Alkermes, Inc. is a biotechnology company that specializes in the development of sophisticated drug delivery technologies.
4
The Anatomy of Melancholy - Tom 2 - Strona 286
2 Christophorus Ayrerus prefers Bezoar's stone, and the confection of Alkermes, before other cordials, and Amber in some cases. 3 Alkermes comforts the inner parts ; and Bezoar stone hath an especial virtue against all melancholy affections, ...
Robert Burton, Arthur Richard Shilleto,
1893
5
Pharmaceutical Applications of Polymers for Drug Delivery - Strona 9
... Trade Name Manufacturer Properties Poly(D-Lactide) (D-PLA) Purasorb PD PURAC Semi-crystalline PoIy(L-Lactide) (L-PLA) Purasorb PL Lactel L-PLA Medisorb 100L PURAC Birmingham Polymers Inc. (BPI) Alkermes Inc Semi-crystalline ...
6
Purchasing and Supply Chain Management - Strona 281
Though Alkermes could see specific responses and detail, such data did not reveal the identity of the person or supplier that completed the survey. Data were aggregated to identify trends/areas for improvement that were, in turn, presented ...
Robert Monczka, Robert Handfield, Larry Giunipero,
2015
7
The SAGE Handbook of Healthcare - Strona 607
Alkermes received funding for development of the inhaler system, milestone payments, and royalties on sales. In February 2002, the two companies announced they were building a facility dedicated to the manufacture of inhaled products.
Decision Resources Inc,
2008
8
Plunkett's Biotech & Genetics Industry Almanac 2009: The ...
ALKERMES INC www.alkermes.com Industry Group Code: 325412A Ranks within this company's industry group: Sales: 4 Profits: 2 Drugs: Other: Discovery: AgriBio: Licensing: Genomics/Proteomics: Manufacturing: Y Tissue Replacement: ...
9
Plunkett's Biotech & Genetics Industry Almanac 2008: ...
ALKERMES INC www.alkermes.com Drugs: Other: Discovery: AgriBio: Licensing: Genomics/Proteomics: Manufacturing: Y Tissue Replacement: Development: Y Generics: TYPES OF BUSINESS: Drug Delivery Systems Pulmonary Drug ...
10
Plunkett's Biotech & Genetics Industry Almanac 2006: The ...
Michael A. Wall, Chmn. Priya Jambhekar, Global VP-Regulatory Affairs Alkermes, Inc. specializes in the development of sophisticated drug delivery technologies. Two of the company's main areas of focus, ProLease and Medisorb injectable ...
Jack W. Plunkett, Plunkett Research, Ltd,
2005
用語«ALKERMES»を含むニュース項目
国内外の報道機関が語った内容や、次のニュース項目の文脈から
alkermesという用語がどのように使われているかを調べてみましょう。
Alkermes (ALKS) Stock Price Target Upped at Barclays
This week the U.S. Food and Drug Administration approved Alkermes's once-monthly schizophrenia drug Aristada, and although the approval wasn't a surprise, ... «TheStreet.com, 10月 15»
FDA Approves Alkermes' Schizophrenia Treatment Aristada
The Food and Drug Administration on Monday approved Alkermes ALKS 1.71 % PLC's schizophrenia treatment clearing the way for the Dublin-based ... «Wall Street Journal, 10月 15»
Today's Dead Cat Bounce Stock Is Alkermes (ALKS)
Trade-Ideas LLC identified Alkermes ( ALKS) as a "dead cat bounce" (down big yesterday but up big today) candidate. In addition to specific proprietary factors, ... «TheStreet.com, 9月 15»
Alkermes (ALKS) Aristada Review Date Postponed by FDA
Alkermes plc (ALKS - Analyst Report) announced that the FDA has said that it needs more time to review the company's New Drug Application for Aristada ... «Zacks.com, 8月 15»
Alkermes Provides Update on FDA Review of ARISTADA™ for the …
DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has advised Alkermes that it ... «Business Wire, 8月 15»
Alkermes plc Reports Second Quarter 2015 Financial Results
“ARISTADA, our long-acting atypical antipsychotic product candidate for schizophrenia, is leading the next wave of Alkermes' emerging blockbusters that offer ... «Business Wire, 7月 15»
Alkermes to Present Clinical Data on ALKS 8700 at Annual Meeting …
INDIANAPOLIS & DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) today announced that data from its phase 1, randomized, double-blind clinical ... «Business Wire, 5月 15»
Alkermes looks to schizophrenia drug approval as sales jump 24%
Chief executive Richard Pops said Alkermes was “on the threshold of the next phase of growth and is in the midst of an extremely active time at the company as ... «Irish Times, 4月 15»
Alkermes heads to Phase III with a schizophrenia drug designed to …
Alkermes ($ALKS) unveiled more positive data for a schizophrenia drug the company believes can treat the disease without spurring weight gain, beating a path ... «FierceBiotech, 4月 15»
Alkermes to Sell Georgia Facility, Pain-Drug Rights to Recro Pharma
In addition to the facility, which Alkermes acquired through its 2011 purchase of ... s drug-technology unit, Recro will receive rights to Alkermes' pain treatment ... «Wall Street Journal, 3月 15»